TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
TIM-3 可作为高危软组织肉瘤 (HR-STS) 特定亚组患者的潜在免疫治疗靶点
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15102735
Berclaz, Luc M; Altendorf-Hofmann, Annelore; Lindner, Lars H; Burkhard-Meier, Anton; Di Gioia, Dorit; Dürr, Hans Roland; Klein, Alexander; Albertsmeier, Markus; Schmidt-Hegemann, Nina-Sophie; Klauschen, Frederick; Knösel, Thomas